- Description
- Specifications
Catalog #: WNV-001
Description:
The E.Coli derived recombinant protein contains the West-Nile N-terminus Envelope Virus immunodominant regions. The protein is fused with 6xHis tag. Mw~42kDa.
Amino Acid Sequence:
MQLKGTTYGV CSKAFKFLGT PADTGHGTVV LELQYTGTDG PCKVPISSVA SLNDLTPVGR LVTVNPFVSV ATANAKVLIE LEPPFGDSYI VVGRGEQQIN HHWHKSGSSI GKAFTTTLKG ALEMQLKGTT YGVCSKAFKF LGTPADTGHG TVVLELQYTG TDGPCKVPIS SVASLNDLTP VGRLVTVNPFV SVATANAKVL IELEPPFGDS YIVVGRGEQQI NHHWHKSGSS IGKAFTTTLK GALEMQLKGT TYGVCSKAFK FLGTPADTGH GTVVLELQYT GTDGPCKVPI SSVASLNDLT PVGRLVTVNP FVSVATANAK VLIELEPPFG DSYIVVGRGE QQINHHWHKS GSSIGKAFTT TLKGALEHHH HHH
Applications:
Antigen in ELISA and Western blots, excellent antigen for detection of West-Nile virus with minimal specificity problems.
Method:
Purified by proprietary chromatographic technique.
Purity:
Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Formulation:
(1mg/ml) 20mM Phosphate buffer pH 7.5.
Specificity:
Immunoreactive with sera of West Nile virus infected individuals.
Storage:
WNV Envelope although stable at 4 °C for 1 week, should be stored below -18 °C.
Please prevent freeze thaw cycles.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
